2
Phototherapy Treatment and Exchange Transfusion for Severe Hyperbilirubinaemia In TERM infants most cases of Kernicterus occur when SBR greater than 425umol/l. SBR > 425umol/l or SBR at exchange transfusion level is a medical EMERGENCY. Immediate Exchange Transfusion recommended if signs of acute bilirubin encephalopathy or if SBR above exchange transfusion line and unresponsive to phototherapy. Contraindications to Phototherapy: Congenital porphyria or a family history of porphyria, use of drugs that are photosensitisers. Plot Serum Bilirubin(SBR) level on Phototherapy Chart-AAP or NICE If above treatment line start Phototherapy. Re-check Serum Bilirubin(SBR) within 2-6 Hours If SBR > 425umol/l re-check SBR within 3 hours. Continue Phototherapy until SBR at least 50umol/l below the phototherapy treatement line level as per AAP or NICE guidelines. If DCT Positive: Repeat clinical assessment, including SBR, within 24 hours. If DCT positive the infant needs review and Hb check within 2 weeks. If Direct Coombes Test (DCT) negative: Repeat clinical assessment within 48 hours. OR Transcutaneous Bilirubin (TCB) should NOT be used to guide phototherapy. If SBR continues to rise despite intensive photopherapy this suggests haemolysis. Longer Phototherapy will usually be necessary if DCT Positive. If SBR is rising rapidly or SBR within 50umol/l of exchange transfusion level, consider IVIG 0.5- 1g/kg , this can be repeated in 12 hours. Consider multiple lights and fibre optic blanket if level approaching exchange transfusion level, Fluid requirements may increase because of insensible losses. Paediatrics and Neonatology Clinical Programme Algorithms

Phototherapy Treatment and Exchange Transfusion … · Phototherapy Treatment and Exchange Transfusion for Severe Hyperbilirubinaemia In TERM infants most cases of Kernicterus occur

Embed Size (px)

Citation preview

Page 1: Phototherapy Treatment and Exchange Transfusion … · Phototherapy Treatment and Exchange Transfusion for Severe Hyperbilirubinaemia In TERM infants most cases of Kernicterus occur

Phototherapy Treatment and Exchange Transfusion for Severe Hyperbilirubinaemia

In TERM infants mostcases of Kernicterusoccur when SBR greaterthan 425umol/l.

SBR > 425umol/l or SBRat exchange transfusionlevel is a medicalEMERGENCY.

Immediate ExchangeTransfusionrecommended if signs ofacute bilirubinencephalopathy or ifSBR above exchangetransfusion line andunresponsive tophototherapy.

Contraindications toPhototherapy:

Congenital porphyria or afamily history ofporphyria, use of drugsthat are photosensitisers.

Plot Serum Bilirubin(SBR) level on Phototherapy Chart-AAP orNICE

If above treatment line start Phototherapy.

Re-check Serum Bilirubin(SBR) within 2-6 HoursIf SBR > 425umol/l re-check SBR within 3 hours.

Continue Phototherapy until SBR at least 50umol/l below thephototherapy treatement line level as per AAP or NICE

guidelines.

If DCT Positive: Repeatclinical assessment,

including SBR, within 24hours.

If DCT positive the infantneeds review and Hbcheck within 2 weeks.

If Direct Coombes Test(DCT) negative:Repeat clinical

assessment within 48hours.

OR

Transcutaneous Bilirubin(TCB) should NOT beused to guidephototherapy.

If SBR continues to risedespite intensivephotopherapy thissuggests haemolysis.

Longer Phototherapy willusually be necessary ifDCT Positive.

If SBR is rising rapidly orSBR within 50umol/l ofexchange transfusionlevel, consider IVIG 0.5-1g/kg , this can berepeated in 12 hours.

Consider multiple lightsand fibre optic blanket iflevel approachingexchange transfusionlevel, Fluid requirementsmay increase because ofinsensible losses.

Paediatrics and Neonatology Clinical Programme Algorithms

Page 2: Phototherapy Treatment and Exchange Transfusion … · Phototherapy Treatment and Exchange Transfusion for Severe Hyperbilirubinaemia In TERM infants most cases of Kernicterus occur

For infants less than 35 weeks gestation, and for exchange transfusion graphs we recommend use of NICE Guidelines Neonatal Jaundice TreatmentThreshold Graphs http://guidance.nice.org.uk/CG98/treatmentthresholdgraph/xls/English

References:

1. Alkalay AL, Simmons CF. Hyperbilirubinaemia in term infants. Pediatr 2005;115:824.

2. Neonatal Jaundice, Clinical Guidelines. National Collaborating Centre for Women’s and Child Health. NICE 2010.

3. Guidelines for detection, management and prevention of hyperbilirubinaemia in term and late preterm infants. Fetus and Newborn committee,Canadian Paediatric Society. Pediatr Child Health 2007;12:401-7.

This care pathway has been produced by the National Paediatric and Neonatology Clinical Programme. It is aimed at medical, nursing andallied health professionals working in Irish neonatal units.

Algorithm number:

Revision number:

Date of Last Update:

Approval date:

N19

2.0

Oct 2013

13/01/14

Document drafted by:

Document Status:

Document approved by:

Revision date:

National Paediatric and Neonatology Clinical Programme

Approved

Paediatric and Neonatology Clinical Programme Working GroupNeonatal Clinical Advisory Group

13/01/16